Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HPV, Human Papillomavirus Viruses, Human Papilloma Virus Vaccine”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT05680454
What this trial is testing

A Phase I Trial Evaluate the Safety and Tolerability Profile of HPV Vaccine

Who this might be right for
Human Papillomavirus Infection
Beijing Health Guard Biotechnology, Inc 160
Large-scale testing (Phase 3)Study completedNCT01047345
What this trial is testing

V503, a 9-valent Human Papillomavirus (9vHPV) Vaccine in Females 12-26 Years of Age Who Have Previously Received GARDASIL™ (V503-006)

Who this might be right for
Cervical CancersVulvar CancersVaginal Cancers+1 more
Merck Sharp & Dohme LLC 924
Large-scale testing (Phase 3)Looking for participantsNCT05262010
What this trial is testing

A Phase III Clinical Trial of a 11-valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) in Chinese Women Aged 9-45 Years

Who this might be right for
HPV InfectioNHPV-Related Carcinoma
National Vaccine and Serum Institute, China 13,500
Large-scale testing (Phase 3)Study completedNCT03903562
What this trial is testing

Immunobridging Study of 9- Valent Human Papillomavirus (9vHPV) Vaccine (V503) in Chinese Females 9 to 45 Years of Age (V503-024)

Who this might be right for
Papillomavirus Infections
Merck Sharp & Dohme LLC 1,990
Not applicableActive Not RecruitingNCT05742386
What this trial is testing

Impact of Standing Orders Optimization

Who this might be right for
Human Papilloma Virus
UNC Lineberger Comprehensive Cancer Center 27
Not applicableEnded earlyNCT01290393
What this trial is testing

Post-marketing Study to Assess the Safety of CERVARIX When Used in the United States and in Canada

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 2
Not applicableEnded earlyNCT06367699
What this trial is testing

Conversational Agents to Improve HPV Vaccine Acceptance in Primary Care (ECA-HPV)- Clinical Trial

Who this might be right for
Human Papilloma Virus
Tufts Medical Center 29
Testing effectiveness (Phase 2)Study completedNCT00551187
What this trial is testing

Evaluate Tolerability and Immunogenicity of V504 Administered Concomitantly With GARDASIL (V504-001)(COMPLETED)

Who this might be right for
Cervical CancerVulvar CancerVaginal Cancer+2 more
Merck Sharp & Dohme LLC 620
Not applicableUnknownNCT00666107
What this trial is testing

Pilot Study to Determine the Safety and Efficacy of Gardasil Against the Human Papilloma Virus (HPV) in HIV-infected Men

Who this might be right for
Anal CancerHIV Infections
Southern California Institute for Research and Education 150
Not applicableStudy completedNCT03497936
What this trial is testing

Marketability of a Technology-based Intervention to Increase HPV Vaccination

Who this might be right for
Human Papilloma Virus
Real Prevention, LLC 360
Not applicableStudy completedNCT03824093
What this trial is testing

High and Low Resource Interventions to Promote HPV Vaccines

Who this might be right for
Human Papilloma VirusTdap - Tetanus, Diphtheria and Acellular Pertussis VaccinationMeningitis, Meningococcal+2 more
Children's Mercy Hospital Kansas City 225
Not applicableActive Not RecruitingNCT05744960
What this trial is testing

Impact of Financial Incentives

Who this might be right for
Human Papilloma Virus
UNC Lineberger Comprehensive Cancer Center 34
Large-scale testing (Phase 3)Study completedNCT00316706
What this trial is testing

Human Papilloma Virus (HPV) Vaccine Trial in Young Adolescent Women With GlaxoSmithKline Biologicals' (GSK Bio) HPV-16/18 Vaccine

Who this might be right for
Cervical Intraepithelial NeoplasiaPapillomavirus Infection
GlaxoSmithKline 1,245
Early research (Phase 1)Study completedNCT03676101
What this trial is testing

Evaluate the Safety and Primary Immunogenicity of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females

Who this might be right for
Cervical CancersVulvar CancerVaginal Cancer+12 more
Shanghai Bovax Biotechnology Co., Ltd. 90
Not applicableUnknownNCT04671823
What this trial is testing

Changes in the Prevalence of Oncogenic HPV Types

Who this might be right for
Papillomavirus VaccinesPapillomavirus Infections
Kanazawa Medical University 1,500
Not applicableStudy completedNCT04438291
What this trial is testing

HPV Vaccination Health-promotion Programme on Vaccine Acceptance and Uptake Among Female Adolescents

Who this might be right for
HPV InfectionHealth BehaviorHealth Attitude
Chinese University of Hong Kong 1,340
Testing effectiveness (Phase 2)Looking for participantsNCT07407569
What this trial is testing

Developing a First-void Urine-based Infection Model to Study HPV-specific Antibody-virion Interaction Before and After HPV Vaccination

Who this might be right for
Human Papilloma Virus Infection Type 16
Universiteit Antwerpen 50
Large-scale testing (Phase 3)Study completedNCT04772534
What this trial is testing

Immunogenicity and Safety of the 9-valent Human Papillomavirus (9vHPV) Vaccine in Japanese Boys and Girls (V503-066)

Who this might be right for
Papillomavirus Infections
Merck Sharp & Dohme LLC 314
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06681636
What this trial is testing

Effector and Memory Immune Responses to HPV Vaccination in Vietnamese Women Post Virus Exposure

Who this might be right for
HPV InfectionCervical CancerAnogenital Cancer+1 more
National Institute of Hygiene and Epidemiology, Vietnam 300
Large-scale testing (Phase 3)Study completedNCT00481767
What this trial is testing

Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus (HPV) Vaccine (GSK580299) in Healthy Female Subjects 10-25 Years of Age.

Who this might be right for
Human Papillomavirus (HPV) Infection
GlaxoSmithKline 676
Next Page